Mednax Reports Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St ends higher on cool inflation data, strong earnings
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices make small gain on smaller US inventory draw
- ASML capacity upgrade soothes AI chip bottleneck fears
MEDNAX (MD) Tops Q4 EPS by 8c; Issues 2022 EBITDA Guidance
February 17, 2022 6:08 AM ESTMEDNAX (NYSE: MD) reported Q4 EPS of $0.52, $0.08 better than the analyst estimate of $0.44. Revenue for the quarter came in at $499 million versus the consensus estimate of $483.83 million.
On a preliminary basis, Mednax anticipates that its 2022 Adjusted EBITDA, as defined above, will be at least $270... More
